- Home
- Products
- Customized FluoroAb™
- VTCN1
- Anti-VTCN1 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester
Anti-VTCN1 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4125)
This product is comprised of an Human Anti-VTCN1 IgG1-kappa (Clone 2) labeled with iFluor® 430 Succinimidyl Ester. iFluor® 430 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- VTCN1
- Overview
- Human Anti-VTCN1 IgG1-kappa (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 430 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 433/498
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS4125. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-506 | Anti-VTCN1-MC-vc-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-C5 MAb (Clone 25)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7824)
- Anti-VEGFA MAb (Clone 14)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16933)
- Sibrotuzumab-iFluor 532 (CAT#: ADC-FL-1426)
- Anti-STEAP1 MAb (Clone 3)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7164)
- Anti-CSF2 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14037)
- Anti-IGF1R MAb (Clone 7)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4366)
- Rilotumumab-PBlue (CAT#: ADC-FL-1602)
- Anti-TNFRSF10B MAb (Clone 8)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11741)
- Anti-FLAG MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13370)
- Anti-CEACAM5 MAb (Clone 8)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7189)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.